Search Browse Earnings

Renalytix plc — SlamSEC

Renalytix plc

OTC:RNLXYOTC:RENXF

Services-Medical Laboratories·LONDON

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$100,000

FY 2023

Adj. EBITDA

-$41.7M

-41713.0% margin

FY 2024

Net Income

-$45.6M

-45607.0% margin

FY 2024

EPS (Diluted)

-$0.55

FY 2024

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$24.7M

FY 2024

Total Debt

—

Net Cash

$24.7M

FY 2023

Enterprise Value

—

Debt / EBITDA

0.6x

FY 2023

EV / EBITDA

—

Employees

—